An uptick in non-oil non-gold imports is likely in the coming months as domestic demand expands, at a time when exports could weaken due to mounting tariff pressures.
India's upcoming BRICS Chairship in 2026, a firm stand against terrorism, a renewed call for UN Security Council (UNSC) reforms, and alarm over trade-restrictive measures dominated discussions at the BRICS Ministers of Foreign Affairs meeting held on the margins of the 80th United Nations G
Speaking on behalf of Chinese President Xi Jinping at the 80th session of the United Nations General Assembly (UNGA) in New York, Li highlighted the need for international cooperation to maintain economic stability.
The Ministry of External Affairs stated on Friday that India is closely monitoring the impact of US President Donald Trump's announcement to impose tariffs of up to 100% on imports of branded and patented pharmaceutical drugs, effective from October 1, 2025.
India rejected NATO Secretary-General Mark Rutte's claim that PM Modi spoke to Russian President Putin after US tariffs, calling it "factually incorrect and entirely baseless." The MEA said no such talks occurred, urged NATO to act responsibly, and reaffirmed India's right to safeguard na
The Pharmaceutical companies and chemists in Shimla have begun implementing the revised GST night tariff on medicines, bringing much-needed relief to patients and the poor.
Samajwadi Party chief Akhilesh Yadav on Friday termed Bharatiya Janata Party's foreign policy a "failure", blaming the government for the "suffering" of India's businesses and trade due to the tariffs imposed by the US.
European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI).
Speaking to reporters here, Pawar stated that it was India's responsibility to respond to decisions concerning the country in a dignified manner and to solely increase the use of swadeshi goods.
India's pharmaceutical exports are not expected to face a major impact following the recent announcement of a 100 per cent tariff on branded and patented pharmaceutical products by the US, said Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance (IPA).
Americans will be the first to be affected, said Niranjan Hiranandani, Founder and Chairman of the Hiranandani Group on Friday, in response to U.S. President Donald J. Trump's announcement of a 100 per cent tariff on branded and patented pharmaceutical products.
Chairperson of the topmost Pharmaceutical company, Pharmexcil, which earns 40 - 50 per cent of its total revenues from the American market also said, "Generic drugs are not impacted".